Rapid Serological Tests for SARS-CoV-2: Diagnostic Performance of 4 Commercial Assays

OBJECTIVE: To assess the diagnostic performance of lateral flow immunochromatographic assays (LFAs) of 4 different manufacturers to identify SARS-CoV-2 antibodies (IgM, IgG, or total), comparing them with the nucleic acid amplification test (NAAT) or the clinical defined test (definite or probable S...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida, Sérgio M., Spalanzani, Regiane N., Nogueira, Meri B., Sanada, Beatriz, Cavalli, Barbara M., Rotta, Indianara, Takahashi, Gislene R.A., Pereira, Luciane A., Moreira, Francielli B., Dino, Carolina L.T., Graf, Maria E., de Almeida, Bernardo M.M., Domino, Natalia R., Genelhoud, Gustavo, Bochnia-Bueno, Lucas, Raboni, Sonia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339017/
https://www.ncbi.nlm.nih.gov/pubmed/33887722
http://dx.doi.org/10.1159/000516776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339017/
https://www.ncbi.nlm.nih.gov/pubmed/33887722
http://dx.doi.org/10.1159/000516776

Ejemplares similares